AVTXAvalo Therapeutics, Inc.

$13.43-0.37% 1Y

Is the price fair?

What AVTX's price assumes

Price / book
11.5

Price / book · as of 2026-Q1

Details›
Price / bookas of 2026-Q1
11.5
Market capitalisation
$706M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.